Join
Live feed
·
PRReleasevia Quantisnow
Pharming Group N.V. ADS each representing 10 logo

Pharming presents positive Phase II topline data for leniolisib in genetic PIDs with immune dysregulation at ESID 2026

ByQuantisnow·Wall Street's wire, on your screen.
PHAR· Pharming Group N.V. ADS each representing 10
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PHAR (Pharming Group N.V. ADS each representing 10) and more on Quantisnow.